Emergent BioSolutions Receives $22.3 Million BioThrax Order Modification
The company said the modification exercises an option period under an existing delivery order to supply BioThrax to the U.S. Department of War.
Story updates
09:08:43 PM UTC
SquawkNews
Emergent received an option-period modification under an existing order worth up to $22.3M to supply BioThrax to the U.S. Department of War. The first delivery, valued at approximately $7.4M, will begin this year; remaining deliveries are expected in 2027.Material DetailsContext by AI AnalystThis i…